These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16081672)

  • 1. Biotransformation of a GABAA receptor partial agonist in sprague-dawley rats and cynomolgus monkeys: identification of two unique N-carbamoyl metabolites.
    Shaffer CL; Gunduz M; O'Connell TN; Obach RS; Yee S
    Drug Metab Dispos; 2005 Nov; 33(11):1688-99. PubMed ID: 16081672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition.
    Shaffer CL; Gunduz M; Ryder TF; O'Connell TN
    Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel N-carbamoyl glucuronide: in vitro, in vivo, and mechanistic studies.
    Gunduz M; Argikar UA; Baeschlin D; Ferreira S; Hosagrahara V; Harriman S
    Drug Metab Dispos; 2010 Mar; 38(3):361-7. PubMed ID: 20008038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys.
    Christopher LJ; Cui D; Li W; Barros A; Arora VK; Zhang H; Wang L; Zhang D; Manning JA; He K; Fletcher AM; Ogan M; Lago M; Bonacorsi SJ; Humphreys WG; Iyer RA
    Drug Metab Dispos; 2008 Jul; 36(7):1341-56. PubMed ID: 18420785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metabolite.
    Shaffer CL; Ryder TF; Venkatakrishnan K; Henne IK; O'Connell TN
    Drug Metab Dispos; 2009 Jul; 37(7):1480-9. PubMed ID: 19339375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in the formation of vabicaserin carbamoyl glucuronide.
    Tong Z; Chandrasekaran A; DeMaio W; Jordan R; Li H; Moore R; Poola N; Burghart P; Hultin T; Scatina J
    Drug Metab Dispos; 2010 Apr; 38(4):581-90. PubMed ID: 20032194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo metabolism of a gamma-secretase inhibitor BMS-299897 and generation of active metabolites in milligram quantities with a microbial bioreactor.
    Zhang D; Hanson R; Roongta V; Dischino DD; Gao Q; Sloan CP; Polson C; Keavy D; Zheng M; Mitroka J; Yeola S
    Curr Drug Metab; 2006 Dec; 7(8):883-96. PubMed ID: 17168689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of a 14C/3H-labeled GABAA receptor partial agonist in rat, dog and human liver microsomes: evaluation of a dual-radiolabel strategy.
    Shaffer CL; Langer CS
    J Pharm Biomed Anal; 2007 Mar; 43(4):1195-205. PubMed ID: 17150324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
    Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
    Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of sertindole: identification of the metabolites in the rat and dog, and species comparison of liver microsomal metabolism.
    Sakamoto K; Nakamura Y; Aikoh S; Baba T; Perregaard J; Pedersen H; Moltzen EK; Mulford DJ; Yamaguchi T
    Xenobiotica; 1995 Dec; 25(12):1327-43. PubMed ID: 8719908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'- (methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)- 1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR.
    Mutlib AE; Shockcor J; Chen SY; Espina RJ; Pinto DJ; Orwat MJ; Prakash SR; Gan LS
    Chem Res Toxicol; 2002 Jan; 15(1):48-62. PubMed ID: 11800597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.
    Obach RS; Reed-Hagen AE; Krueger SS; Obach BJ; O'Connell TN; Zandi KS; Miller S; Coe JW
    Drug Metab Dispos; 2006 Jan; 34(1):121-30. PubMed ID: 16221753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolism of [14C]-levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, in humans, monkeys, and rats.
    Brunner V; Maynadier B; Chen L; Roques L; Hude I; Séguier S; Barthe L; Hermann P
    Drug Des Devel Ther; 2015; 9():3199-215. PubMed ID: 26150694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.
    Berry LM; Liu J; Colletti A; Krolikowski P; Zhao Z; Teffera Y
    Drug Metab Dispos; 2014 Apr; 42(4):707-17. PubMed ID: 24423753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
    Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
    Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of a dopamine receptor partial agonist in rats, including an unusual N-dearylation reaction.
    Zhao SX; Wang WW; Walker GS; Zhang L; Obach RS
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):266-79. PubMed ID: 21383524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.